<DOC>
	<DOCNO>NCT01332448</DOCNO>
	<brief_summary>Roche GSK carry meta-analysis liver function data trial orlistat establish whether indication liver toxicity . The motivation cumulative assessment drug-induced liver injury ( DILI ) conduct FDA follow spontaneous report liver toxicity people take Xenical Alli .</brief_summary>
	<brief_title>Meta-analysis Orlistat Laboratory Data From Placebo-controlled Clinical Trials</brief_title>
	<detailed_description />
	<mesh_term>Orlistat</mesh_term>
	<criteria>1 . The trial must randomize placebocontrolled 2 . The orlistat dose must 60mg 120mg 3 . Data ALT BIL must available 4 . The nominal treatment period must 16 week longer 1 . If crossover trial find , data first period exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Xenical</keyword>
	<keyword>Alli</keyword>
	<keyword>safety</keyword>
	<keyword>meta-analysis</keyword>
	<keyword>liver-function test</keyword>
	<keyword>Roche</keyword>
	<keyword>orlistat</keyword>
</DOC>